Hemangioma should not be referred and should be monitored.
Interactive guideline should be used at every visit.

Complications or potential risk of complications (Ulceration, Visual Compromise, Feeding difficulties, Stridor)

Central face and/or ears

Breast (in female)

Midline lumbosacral

Size ≥ 4 cm (focal or segmental)

Number of hemangiomas ≥ 5

Complications or potential risk of complications (Ulceration, Visual Compromise, Feeding difficulties, Stridor)

Central face and/or ears

Breast (in female)

Midline lumbosacral

Size ≥ 4 cm (focal or segmental)

Number of hemangiomas ≥ 5

Other facial areas than those mentioned previously (see part A)

Neck, diaper area, scalp

≥ 1 cm on other facial area than those mentioned previously (see part A)

2 – 4 cm on other body area than those mentioned previously (see part A)

The infant is < than 2 months

The infant is ≥ 2 and ≤ 4 months with an evident growth within last 2 weeks

Other facial areas than those mentioned previously (see part A)

Neck, diaper area, scalp

≥ 1 cm on other facial area than those mentioned previously (see part A)

2 – 4 cm on other body area than those mentioned previously (see part A)

The infant is < than 2 months

The infant is ≥ 2 and ≤ 4 months with an evident growth within last 2 weeks